Stay updated on Tepotinib & Gefitinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Tepotinib & Gefitinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tepotinib & Gefitinib in NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Taoyuan, Taiwan has been added as a site and Taoyuan District, Taiwan has been removed from the study locations. This updates the geographic footprint of the trial sites for INSIGHT.
    Difference
    0.0%
    Check dated 2026-05-03T15:50:51.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page’s footer “Revision” has been updated from v3.5.2 to v3.5.3, indicating a platform/version change rather than a change to the trial’s published information.
    Difference
    0.0%
    Check dated 2026-04-26T15:36:33.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    System revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T13:56:26.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    46 days ago
    Change Detected
    Summary
    Site revision updated to v3.5.0, replacing the prior v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-21T17:32:11.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replaces v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-07T13:12:17.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The page revision history shows removal of v3.4.1 and addition of v3.4.2; there are no changes to the study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T13:57:59.000Z thumbnail image

Stay in the know with updates to Tepotinib & Gefitinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tepotinib & Gefitinib in NSCLC Clinical Trial page.